Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

non-small-cell lung cancer

  • You have access
    Paclitaxel Impedes EGFR-mutated PC9 Cell Growth via Reactive Oxygen Species-mediated DNA Damage and EGFR/PI3K/AKT/mTOR Signaling Pathway Suppression
    MD MOHIUDDIN and KAZUO KASAHARA
    Cancer Genomics & Proteomics September 2021, 18 (5) 645-659; DOI: https://doi.org/10.21873/cgp.20287
  • You have access
    OIP5-AS1 Promotes Proliferation of Non-small-cell Lung Cancer and Head and Neck Squamous Cell Carcinoma Cells
    YOJIRO KOTAKE, NATSUMI MATSUNAGA, TAKAHIRO WAKASAKI and RYOTARO OKADA
    Cancer Genomics & Proteomics July 2021, 18 (4) 543-548; DOI: https://doi.org/10.21873/cgp.20279
  • Open Access
    Usefulness of Nanofluidic Digital PCR Arrays to Quantify T790M Mutation in EGFR-mutant Lung Adenocarcinoma
    KAZUTOSHI ISOBE, YOSHINOBU HATA, NAOBUMI TOCHIGI, KYOHEI KABURAKI, HIROSHI KOBAYASHI, TAKASHI MAKINO, HAJIME OTSUKA, FUMIAKI ISHIDA, NAO HIROTA, GO SANO, KEISHI SUGINO, SUSUMU SAKAMOTO, YUJIRO TAKAI, KAZUTOSHI SHIBUYA, AKIRA IYODA and SAKAE HOMMA
    Cancer Genomics & Proteomics January 2015, 12 (1) 31-37;
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire